Production (Stage)
Zealand Pharma A/S
ZLDPF
$62.36
$0.01560.03%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -11.80% | 98.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.80% | 98.92% | |||
| Cost of Revenue | -2.06% | 105.98% | |||
| Gross Profit | -12.27% | -24.00% | |||
| SG&A Expenses | -34.10% | 59.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 778.92% | -196.97% | |||
| Total Operating Expenses | 1.12% | 11.06% | |||
| Operating Income | -1.42% | -9.95% | |||
| Income Before Tax | -13.97% | -5.62% | |||
| Income Tax Expenses | -136.71% | 59.53% | |||
| Earnings from Continuing Operations | -13.73% | -5.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.73% | -5.95% | |||
| EBIT | -1.42% | -9.95% | |||
| EBITDA | -0.61% | -11.19% | |||
| EPS Basic | -13.95% | -5.85% | |||
| Normalized Basic EPS | -15.59% | -0.90% | |||
| EPS Diluted | -13.95% | -5.85% | |||
| Normalized Diluted EPS | -15.59% | -0.90% | |||
| Average Basic Shares Outstanding | -0.20% | 0.11% | |||
| Average Diluted Shares Outstanding | -0.20% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||